Genome editing of PAR2 through targeted delivery of CRISPR-Cas9 system for alleviating acute lung inflammation via ERK/NLRP3/IL-1β and NO/iNOS signalling
Xin Zhuo(Sichuan University), Yuhong Jiang(Southwest Jiaotong University)
Cited by 11
Related Papers
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells
|Journal of Pharmacology and Experimental Therapeutics|2017|66
Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation
|Frontiers in Pharmacology|2021|24